Literature DB >> 23721483

Frequency of and risk factors for symptomatic bone fractures in patients with systemic lupus erythematosus.

S Ekblom-Kullberg1, H Kautiainen, P Alha, M Leirisalo-Repo, H Julkunen.   

Abstract

OBJECTIVES: To study risk factors for symptomatic bone fractures in patients with systemic lupus erythematosus (SLE) and to compare the frequency of fractures between SLE patients and population controls.
METHOD: The study included 222 SLE patients [mean age 47.0 years, disease duration 13.1 years, 204 (92%) women] and 720 population controls living in the metropolitan area of Helsinki. The history of symptomatic bone fractures in SLE patients and controls was recorded by interview, and demographic and clinical data of SLE patients were obtained by interview, clinical examination, and chart review.
RESULTS: A history of at least one symptomatic bone fracture was recorded in 93 (42%) of all 222 patients with SLE. The risk of any fracture in 204 women with SLE compared to controls was 1.8 [95% confidence interval (CI) 1.3-2.4] and fractures in the ankle, hip, and vertebral column were more common than in female controls, with odds ratios (ORs) of 2.0 (95% CI 1.1-3.7), 5.1 (95% CI 1.2-21.5), and 4.0 (95% CI 1.8-8.6), respectively. In 18 men with SLE, compared to male controls, no difference in the frequency of fractures was observed (OR 0.7, 95% CI 0.3-2.0). Risk factors for bone fractures in women with SLE were age (p = 0.008), comorbidity (p = 0.050), and the duration of corticosteroid use (p = 0.025).
CONCLUSIONS: Symptomatic bone fractures, especially in the ankle, hip, and vertebral column, are common in women with SLE. Special attention should be paid to preventing fractures in elderly female patients with comorbidities and a long duration of corticosteroid use.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23721483     DOI: 10.3109/03009742.2013.775331

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  9 in total

Review 1.  Fracture risk and bone mineral density levels in patients with systemic lupus erythematosus: a systematic review and meta-analysis.

Authors:  X Wang; S Yan; C Liu; Y Xu; L Wan; Y Wang; W Gao; S Meng; Y Liu; R Liu; D Xu
Journal:  Osteoporos Int       Date:  2016-01-11       Impact factor: 4.507

2.  Prevalence and Risk Factors of Reduced Bone Mineral Density in Systemic Lupus Erythematosus Patients: A Meta-Analysis.

Authors:  Jumei Xia; Ran Luo; Shuiming Guo; Yi Yang; Shuwang Ge; Gang Xu; Rui Zeng
Journal:  Biomed Res Int       Date:  2019-02-20       Impact factor: 3.411

3.  Incidence and risk factors for osteoporotic fractures in patients with systemic lupus erythematosus versus matched controls.

Authors:  Chang Seong Kim; Kyung-Do Han; Jin Hyung Jung; Hong Sang Choi; Eun Hui Bae; Seong Kwon Ma; Soo Wan Kim
Journal:  Korean J Intern Med       Date:  2019-06-26       Impact factor: 2.884

4.  Elevated risk of clinical fractures and associated risk factors in patients with systemic lupus erythematosus versus matched controls: a population-based study in the United Kingdom.

Authors:  I E M Bultink; N C Harvey; A Lalmohamed; C Cooper; W F Lems; T P van Staa; F de Vries
Journal:  Osteoporos Int       Date:  2013-12-03       Impact factor: 4.507

5.  Systemic lupus erythematosus and fractures.

Authors:  Irene E M Bultink; Willem F Lems
Journal:  RMD Open       Date:  2015-08-15

6.  Effects of salvianolate on bone metabolism in glucocorticoid-treated lupus-prone B6.MRL-Fas (lpr) /J mice.

Authors:  Yanzhi Liu; Yang Cui; Xiao Zhang; Xiang Gao; Yanjie Su; Bilian Xu; Tie Wu; Wenshuang Chen; Liao Cui
Journal:  Drug Des Devel Ther       Date:  2016-08-09       Impact factor: 4.162

Review 7.  Bone Disease in Connective Tissue Disease/Systemic Lupus Erythematosus.

Authors:  Irene E M Bultink
Journal:  Calcif Tissue Int       Date:  2017-09-12       Impact factor: 4.333

Review 8.  Bone mineral density and vertebral fractures in patients with systemic lupus erythematosus: A systematic review and meta-regression.

Authors:  Claudia Mendoza-Pinto; Adriana Rojas-Villarraga; Nicolás Molano-González; Erick A Jiménez-Herrera; María de la Luz León-Vázquez; Álvaro Montiel-Jarquín; Mario García-Carrasco; Ricard Cervera
Journal:  PLoS One       Date:  2018-06-13       Impact factor: 3.240

Review 9.  Management of glucocorticoid-related osteoporotic vertebral fracture.

Authors:  Stella Pui Yan Wong; Chi Chiu Mok
Journal:  Osteoporos Sarcopenia       Date:  2020-03-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.